Patent classifications
C
C07
C07K
14/00
C07K14/005
C07K14/08
C07K14/18
C07K14/1816
C07K14/1841
C07K14/1841
Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein
10034936
·
2018-07-31
·
·
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.